These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Saab S; Niho H; Comulada S; Hiatt J; Durazo F; Han S; Farmer DG; Holt C; Yersiz H; Goldstein LI; Ghobrial RM; Busuttil RW Liver Int; 2005 Oct; 25(5):940-5. PubMed ID: 16162150 [TBL] [Abstract][Full Text] [Related]
3. Are posttransplantation protocol liver biopsies useful in the long term? Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213 [TBL] [Abstract][Full Text] [Related]
4. Renal transplantation normalized hydrogen peroxide production of neutrophils within the first day. Jüttner B; Gehrmann A; Breitmeier D; Jaeger K; Weissig A; Bornscheuer A; Piepenbrock S; Scheinichen D Am J Nephrol; 2008; 28(4):531-8. PubMed ID: 18219196 [TBL] [Abstract][Full Text] [Related]
5. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502 [TBL] [Abstract][Full Text] [Related]
6. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580 [TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 6 infection in adult living related liver transplant recipients. Ohashi M; Sugata K; Ihira M; Asano Y; Egawa H; Takada Y; Uemoto S; Yoshikawa T Liver Transpl; 2008 Jan; 14(1):100-9. PubMed ID: 18161770 [TBL] [Abstract][Full Text] [Related]
8. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874 [TBL] [Abstract][Full Text] [Related]
9. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449 [TBL] [Abstract][Full Text] [Related]
10. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968 [TBL] [Abstract][Full Text] [Related]
11. Deficient phospholipase C activity in blood polimorphonuclear neutrophils from patients with liver cirrhosis. Garfia C; García-Ruiz I; Solís-Herruzo JA J Hepatol; 2004 May; 40(5):749-56. PubMed ID: 15094221 [TBL] [Abstract][Full Text] [Related]
12. Mycophenolic acid inhibits PMA-induced activation of the neutrophil respiratory burst. Jüttner B; Bencel M; Weissig A; Studzinski A; Stenger K; Scheinichen D Transpl Infect Dis; 2009 Jun; 11(3):235-40. PubMed ID: 19302273 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of recurrent HCV infection after liver transplantation]. Ostojić R Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241 [TBL] [Abstract][Full Text] [Related]
14. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence. Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088 [TBL] [Abstract][Full Text] [Related]
15. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. Fiuza C; Salcedo M; Clemente G; Tellado JM J Infect Dis; 2000 Aug; 182(2):526-33. PubMed ID: 10915084 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512 [TBL] [Abstract][Full Text] [Related]
17. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846 [TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation. Fábrega E; Orive A; García-Unzueta M; Amado JA; Casafont F; Pons-Romero F Clin Transplant; 2006; 20(3):383-8. PubMed ID: 16824158 [TBL] [Abstract][Full Text] [Related]
20. Peri- and post-operative course of cytokines and the metabolic activity of neutrophils in human liver transplantation. Kubala L; Cíz M; Vondrácek J; Cízová H; Cerný J; Nĕmec P; Studeník P; Dusková M; Lojek A Cytokine; 2001 Nov; 16(3):97-101. PubMed ID: 11741349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]